Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

about

The safety of available treatments options for neuroendocrine tumors.The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.Chemotherapy in NETs: When and how.

P2860

Q39433254-CE94A3C1-5C4C-49BE-8E75-E43018ED98E2 Q39448012-41B6DD18-EE25-49AE-B2A9-7204809805DC Q47692261-130A7291-C648-4B85-9A6E-C1A3ED93F9A1

P2860

Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

Item

http://www.wikidata.org/entity/Q36107481

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Low dose DTIC is effective and ...... entiated neuroendocrine tumors

@ast

Low dose DTIC is effective and ...... entiated neuroendocrine tumors

@en

type

Item

label

Low dose DTIC is effective and ...... entiated neuroendocrine tumors

@ast

Low dose DTIC is effective and ...... entiated neuroendocrine tumors

@en

prefLabel

Low dose DTIC is effective and ...... entiated neuroendocrine tumors

@ast

Low dose DTIC is effective and ...... entiated neuroendocrine tumors

@en

P1476

Low dose DTIC is effective and ...... entiated neuroendocrine tumors

@en

P2093

Anja Rinke

http://www.w3.org/2001/XMLSchema#string

Daniela Mueller

http://www.w3.org/2001/XMLSchema#string

Moushumee Majumder

http://www.w3.org/2001/XMLSchema#string

Sebastian Krug

http://www.w3.org/2001/XMLSchema#string

P2860

Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms--Predictive and Prognostic Markers for Treatment Stratification

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.

Phase I-II study of radiopeptide 177Lu-octreotate in combination with capecitabine and temozolomide in advanced low-grade neuroendocrine tumors.

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor.

Endocrine tumours of the gastrointestinal tract: Chemotherapy.

First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas.

DTIC therapy in patients with malignant intra-abdominal neuroendocrine tumors.

Therapy of malignant APUD cell tumors. Effectiveness of DTIC.

Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours.

P2888

s12885-016-2642-1

P304

645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-016-2642-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Gress

P577

2016-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021025770

http://www.w3.org/2001/XMLSchema#string

P698

27538897

http://www.w3.org/2001/XMLSchema#string

P932

4989525

http://www.w3.org/2001/XMLSchema#string

Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

about

P2860

P2860

Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P6179

P698

P932